相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Teratogenic Potencies of Valproic Acid Derivatives and Their Effects on Biological End-points are Related to Changes in Histone Deacetylase and Erk1/2 Activities
Kamil Gotfryd et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer
Xiaoxin S. Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Epigenetic modulation of gene expression of human leukemia cell lines - induction of cell death and senescence
K. Elknerova et al.
NEOPLASMA (2011)
Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons
Zoya Marinova et al.
NEUROPHARMACOLOGY (2011)
Short-Time Gene Expression Response to Valproic Acid and Valproic Acid Analogs in Mouse Embryonic Stem Cells
Mans Jergil et al.
TOXICOLOGICAL SCIENCES (2011)
Epigenetic modifications in valproic acid-induced teratogenesis
Emily W. Y. Tung et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner
Eun Loo Noh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
Ailsa J. Frew et al.
CANCER LETTERS (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
DNA content, chromatin supraorganization, nuclear glycoproteins and RNA amounts in hepatocytes of mice expressing insulin-dependent diabetes
Maria Luiza S. Mello et al.
MICRON (2009)
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo
Madeleine S. Q. Kortenhorst et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions
Mamoru Fukuchi et al.
NEUROSCIENCE RESEARCH (2009)
Use of intravenous valproic acid for acute migraine
Lawrence A. Frazee et al.
ANNALS OF PHARMACOTHERAPY (2008)
Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells
Yehua Gan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro
Camila M. L. Machado et al.
BMC CANCER (2008)
Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers
Fadi Braiteh et al.
CLINICAL CANCER RESEARCH (2008)
Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo
Siraj Sami et al.
JOURNAL OF BIOCHEMISTRY (2008)
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis
Fumihiko Hayakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
M. F. B. Silva et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Marielle Dejligbjerg et al.
MOLECULAR CANCER (2008)
Modulation of the cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa cells
Pei-Yao Liu et al.
MOLECULAR CANCER RESEARCH (2008)
Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation
Elisabetta Tabolacci et al.
PHARMACOGENETICS AND GENOMICS (2008)
Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells
Jyothsna Rao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O. Soriano et al.
BLOOD (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Valproic acid (VPA) in patients with refractory advanced cancer:: a dose escalating phase I clinical trial
A. Atmaca et al.
BRITISH JOURNAL OF CANCER (2007)
Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes
Snezana Milutinovic et al.
CARCINOGENESIS (2007)
Chromatin supraorganization and extensibility in mouse hepatocytes with development and aging
Alberto S. Moraes et al.
CYTOMETRY PART A (2007)
Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid
LP Qiao et al.
ENDOCRINOLOGY (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
XN Li et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Valproic acid alters chromatin structure by regulation of chromatin modulation proteins
DC Marchion et al.
CANCER RESEARCH (2005)
Chromatin supraorganization and extensibility in mouse hepatocytes following starvation and refeeding
AS Moraes et al.
CYTOMETRY PART A (2005)
Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin
KF Tóth et al.
JOURNAL OF CELL SCIENCE (2004)
Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes
DC Lagace et al.
ENDOCRINOLOGY (2004)
The activity of antiepileptic drugs as histone deacetylase inhibitors
S Eyal et al.
EPILEPSIA (2004)
Valproate induces replication-independent active DNA demethylation
N Detich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation
HJ Shin et al.
ONCOGENE (2003)
Overtreatment in epilepsy: adverse consequences and mechanisms
E Perucca
EPILEPSY RESEARCH (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
